factor for perioperative cardiovascular events. In the multicentre ANESCARDIOCAT study, we also determined that a preoperative serum creatinine level of 177 mmol litre 21 or greater was an independent risk factor for MACCE in a regression model. 9 Since the National Kidney Foundation Practice Guidelines for Chronic Kidney Disease and subsequent guides showed that serum creatinine alone is not an accurate index of glomerular filtration rate (GFR), estimated GFR (eGFR) has been regarded as the best index for assessment of kidney function in health and disease. 2 4 10 11 The equation most widely used to estimate GFR is the Modification of Diet in Renal Disease (MDRD) study equation. However, the Chronic Kidney Disease Epidemiology Collaboration proposed an alternative equation (CKD-EPI) to calculate eGFR that has been shown to be more accurate and predictive than the MDRD study equation and has been gaining acceptance in recent years. 2 12 13 The KDIGO (Kidney Disease Improving Global Outcomes) 2012 Clinical Practice Guidelines recommend that clinical laboratories report eGFR using the 2009 CKD-EPI creatinine equation. 11 To date, most studies in the surgical population evaluating poor renal function and perioperative cardiovascular morbidity and mortality have used serum creatinine alone to define renal impairment. 5 It is well known that serum creatinine concentration can be affected by extrarenal factors and that normal creatinine levels do not always rule out the presence of CKD. 4 The literature evaluating the relationship between eGFR and the occurrence of MACCE in non-cardiac surgery is limited. Even less is known about the possibility of a graded relationship between renal disease stage and the risk of perioperative cardiovascular events. The objective of the current study was to further analyse the relationship between preoperative eGFR and the occurrence of perioperative MACCE in non-cardiac surgery with a goal of defining an eGFR cut-off value for identifying patients at higher risk for MACCE.
Methods
This study is a secondary data analysis of a large prospective multicentre cohort study (ANESCARDIOCAT study) that was carried out to identify risk factors for MACCE in non-cardiac surgical patients. The methods and results of the ANESCARDIOCAT study have been published elsewhere. 9 The current study was not planned when ANESCARDIOCAT was designed, and was carried out afterwards. The study was approved by the research ethics committee of Hospital Germans Trias i Pujol (approval reference number EO-07-027) on behalf of all centres and was conducted in accordance with the Declaration of Helsinki. Signed patient consent was waived because no care interventions were mandated and no protected health information was collected. Interventions other than routine care were not carried out.
The study included patients from 23 participating hospitals in Catalonia recruited between October 2007 and June 2008 during six randomized weeks. Data collection was carried out in all hospitals simultaneously.
Participants
We recruited all middle-aged to elderly patients (≥40 yr of age) undergoing scheduled or emergency non-cardiac operations of intermediate-to-high surgery-specific risk according to the guidelines of the American College of Cardiology (ACC) and the American Heart Association (AHA).
14 All enrolled patients received general or spinal -epidural anaesthesia. Hospital stay for surgery-related reasons was expected to be longer than 24 h. Exclusion criteria were age ,40 yr, childbirth or any obstetrical procedure related to pregnancy, exclusive use of local or peripheral nerve anaesthesia, procedures outside the operating theatre, surgical procedures related to a previous postoperative complication, or ambulatory surgery.
Variables and data collection
The main outcome was occurrence of a perioperative MACCE, defined as any of the following: non-fatal cardiac arrest, acute myocardial infarction, angina, congestive heart failure, new cardiac arrhythmia, stroke, cardiovascular death, or cerebrovascular death. 9 We collected patient characteristic data and potential preoperative risk factors for MACCE. These included the following active cardiac conditions and clinical risk factors: unstable coronary syndromes, decompensated heart failure, significant arrhythmias, severe valvular disease, history of coronary artery disease or congestive heart failure, history of cerebrovascular disease, history of CKD, diabetes mellitus, abnormal ECG, cardiac rhythm other than sinus, hypertension, and other preoperative variables, among them preoperative serum creatinine concentration.
Trained members of the local research team in each hospital were responsible for obtaining preoperative information and for surveillance of perioperative complications. Management of complications was left to the judgement of the attending physicians in each centre. Data were recorded in an online centralized database developed in a secure protocol with qualitycontrol algorithms to validate data entry as described. 9 For the current study, eGFR for each patient was calculated from routine serum creatinine measurements with both the abbreviated isotope dilution mass spectrometry (IDMS)-traceable MDRD 4 15 16 and the CKD-EPI 11 12 equations (Fig. 1) .
To evaluate the distribution and risk relationship of eGFR and MACCE, we classified patients into six groups for both equations according to eGFR (ml min 21 11 13 17 This current classification further acknowledges the importance of dividing stage 3, based on data supporting different outcomes and risk profiles, into categories 3a and 3b. 11 Dependent variables were MACCE occurring either in the operating theatre or after operation up to hospital discharge. We first analysed the distribution of patients and MACCE for both equations in search of possible differences between them and sought to determine whether or not any differences found were relevant for use in risk prediction. All other results were based on the most recently recommended CKD-EPI equation only.
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Statistical analyses
Categorical variables were expressed as the number of cases and percentages, and continuous variables as the median and 25th -75th percentile. We used the Fisher exact test to assess statistically significant differences between the MDRD and CKD-EPI equations in the rate of MACCE in each GFR stage. The measure of agreement between MDRD and CKD-EPI classifications was performed with Cohen's k coefficient. The Mantel-Haenszel test was used to analyse and compare trends in MACCE and length of hospital stay between the eGFR subgroups. The odds ratio (OR) for all-cause mortality and MACCE was calculated using a logistic regression analysis where the independent variable was eGFR. Statistical analyses were performed using the SPSS software package (version 20.0; IBM Corp., Chicago, IL, USA).
Results
Of 3519 surgical patients recruited, 132 were lost to follow-up for outcome, and 1064 were excluded from the present study due to missing data needed to calculate eGFR; eGFR was calculated in the remaining 2323 patients (Fig. 2 ). Patient and procedure characteristics are given in Table 1 (Table 2) . Perioperative MACCE occurred in 4.5% (104) of patients and cardiac-related mortality was 0.5% (11 of 2323 patients).
When we compared the distribution of patients into the six eGFR groups with both equations, the estimated k coefficient was 0.78, showing good agreement between the two equations (Supplementary Table S1 ). Supplementary Table S2 shows the incidence of perioperative MACCE for each group according to each equation. The mean eGFR was 74 ml min 21 for the CKD-EPI equation. Compared with the MDRD equation, for the higher values of eGFR, the CKD-EPI equation led to an upward redistribution of patients to higher stages of eGFR, resulting in a decrease in the number of patients in stages 2 and 3 and an increase in the number of patients in stage 1. There were no statistically significant differences between the two equations in the incidence of MACCE within each specific stage of renal impairment. With the exception of cerebrovascular events, the incidence of all other MACCE increased as preoperative eGFR decreased (Table 3) . Logistic regression analysis showed that the occurrence of any MACCE increased significantly with impairment of renal function (P,0.001), with a marked increase from stage 3b (eGFR ,45 ml min 21 1.73 m 22 ) downwards (OR 1.8 vs 3.9 in 3a and 3b, respectively; P¼0.047). While we did not find a significant relationship between perioperative all-cause mortality and eGFR stage (P¼0.071), we did observe a considerable increase in mortality between stages 3b and 4. Length of hospital stay also correlated with decline in eGFR (Table 4) . 13 27 SCr, serum creatinine concentration in mg dl 21 . Age is expressed in years.
Discussion
Our study describes new insights in the evaluation of cardiovascular risk in the perioperative setting for non-cardiac surgery in patients with CKD. We analysed the effect of preoperative eGFR, calculated according to the new CKD-EPI equation, on MACCE in a broad spectrum of non-cardiac operations.
We determined an eGFR cut-off of 45 ml min 21 1.73 m 22 with which to identify patients at higher risk for such events. These data support routine use of preoperative eGFR instead of creatinine for perioperative cardiovascular risk assessment. In a broad spectrum of non-cardiac procedures of intermediate-to-high surgery-specific risk, we found that the incidence of MACCE increased with the degree of impairment of preoperative eGFR. The increase in complications was particularly evident for eGFR ,45 ml min 21 1.73 m 22 , corresponding to stage 3b of the current CKD classification. While we found a non-significant association between decreasing eGFR and all-cause mortality, we observed a large increase in all-cause mortality for an eGFR ,30 ml min 21 1.73 m 22 , mainly due to non-cardiac death.
To our knowledge, ours is the first cohort study to analyse the relationship between eGFR and perioperative MACCE in a large variety of non-cardiac surgical procedures. While
Mooney and colleagues'
18 meta-analysis found that eGFR was strongly associated with short-and long-term prognosis, this meta-analysis was based mainly on studies carried out in cardiac and vascular surgery patients. The only two studies performed in non-cardiac and non-vascular procedures included in this report involved only a small number of patients and used the old Cockcroft -Gault equation to estimate GFR; one of them evaluated the association with postoperative renal failure exclusively. 19 20 Although the Cockcroft -Gault formula is still widely used and is probably better than isolated creatinine alone, it was developed before standardization of creatinine assays and thus cannot be reexpressed for use with current assays. 11 Ackland and colleagues, 21 using the MDRD study equation, found an increase in perioperative morbidity (all-cause complications) and an increase in the length of hospital stay after elective orthopaedic surgery in patients with a preoperative eGFR ,50 ml min 21 1.73 m 22 .
Our results in a non-cardiac surgery-specific risk population are consistent with previous findings in the general community population. Go and colleagues 22 found an independent graded association between eGFR and risk of death, cardiovascular events, and hospitalization in a large community-based population, with a higher increase in event rates for eGFR ,45 ml 22 . Although the perioperative period is quite different from the non-surgical setting, it is plausible that the risk of major events shows a similar trend. This could be explained by the fact that the prevalence of cardiovascular disease increases with severity of renal impairment, 22 -25 which in turn is consistent with our findings of a higher prevalence of preoperative clinical risk factors as kidney disease progresses. Furthermore, kidney disease has been described as an independent cardiovascular risk factor and even as an ischaemic heart disease risk equivalent. 26 Of particular interest in our study was the use of the CKD-EPI equation to calculate eGFR. To the best of our knowledge, ours is the first study to use this equation to analyse eGFR and its relationship to perioperative cardiovascular disease in the noncardiac surgical population. One of the major limitations of the MDRD study equation is its imprecision and underestimation of measured GFR at higher values (GFR .60 ml min 21 
m 22
). 27 In contrast, the CKD-EPI equation is as accurate as the MDRD study equation for the subgroup of patients with eGFR ,60 ml min 21 1.73 m 22 , whereas it is substantially more accurate for a higher eGFR, thus leading to an upward redistribution of patients to higher stages of renal disease and decreasing the prevalence of stage 3 CKD (eGFR¼30 -59 ml min 21 1.73 m 22 ). The net effect is a decline in the prevalence of CKD. In the general population, this improved calculation of eGFR using the CKD-EPI equation also seems to improve clinical long-term term risk prediction for adverse outcomes (such as end-stage renal disease and cardiovascular and all-cause mortality) than the MDRD study equation in patients with CKD and in patients with a higher eGFR. 13 28 29 Thus, it is generally considered that the advantages of the CKD-EPI equation at a higher GFR make it more applicable than the MDRD study equation for general practice and public health, at least in North America, Europe, and Australia where this formula has been validated. 11 The disagreement that we observed between the two equations in the distribution of patients are consistent with previous findings initially obtained in larger populations. However, we were unable to show any differences in their ability to predict outcome, probably due to the limited number of patients included in our cohort. This limitation is inherent to secondary data analysis of a previous large cohort study where sample size was not calculated specifically for this purpose. Another obvious possible explanation is our short-term follow-up period, since we analysed complications only up to hospital discharge. Current AHA/ACC guidelines on perioperative cardiovascular evaluation and care for non-cardiac surgery integrate the clinical risk factors of the Lee Revised Cardiac Risk Index and define a serum creatinine of 177 mmol litre 21 (2 mg dl 21 ) or higher as an independent predictor of perioperative cardiovascular events. 14 However, it is well known that GFR must decline to approximately half normal before serum creatinine concentration increases above the upper limit of the normal range. For this reason, serum creatinine is currently dismissed as a reliable method to detect kidney dysfunction due to several factors. For instance, age-related decline in muscle mass reduces creatinine generation; consequently, creatinine serum concentration does not reflect age-related decline in GFR and normal creatinine values could correspond to low eGFR. 4 Although the age-related decrease in renal function is considered part of the normal ageing process, this decline in the elderly has been shown to be an independent predictor of complications such as cardiovascular disease and death. 30 -32 Using eGFR, there is a 17% prevalence of patients aged 60 yr or older with eGFR ,60 ml min 21 1.73 m 22 , which corresponds to stage 3 of the previous classification. 4 It is thus not surprising that we diagnosed a greater number of patients with renal disease when using eGFR rather than serum creatinine alone. This result is consistent with previous 20 21 In view of these considerations and based on our own and previous studies, 18 21 we believe that current guidelines on perioperative cardiovascular evaluation for non-cardiac surgery 14 33 should switch from using serum creatinine alone to using eGFR to evaluate the risk of perioperative cardiovascular events. A limitation of our study is that eGFR was calculated retrospectively from a single measurement of serum creatinine concentration. An isolated measurement of kidney function is not enough to diagnose CKD, 4 so we acknowledge the possibility that we might have included patients with some degree of preoperative acute kidney dysfunction. In this regard, it would have been interesting to analyse albuminuria, as the degree of albuminuria has been shown to be a significant risk factor for both CKD progression and cardiovascular disease. 2 11 17 Serum creatinine concentrations were obtained from preoperative laboratory testing and we do not know whether or not these creatinine measurements were calibrated to an assay traceable to IDMS, which is considered the standard method. 13 17 Non-standard methods can slightly overestimate creatinine concentration and hence induce errors in GFR estimates. 4 However, the current Spanish guidelines, published in 2006, strongly recommend that laboratories standardize creatinine calibration to be traceable to IDMS. 34 Another potential limitation of our study is the lack of measurement of prospective cardiac biomarkers for all patients as recommended by other authors. 35 As a result, the rate of MACCE might have been underestimated, as silent cardiac events would not have been detected. It is worth mentioning that TnT measurements (baseline and prospective) have a different significance in CKD than in the general population, since TnT levels are influenced by decreased renal clearance. 36 37 In any case, the definition of MACCE used for the study was broad enough to include most clinically relevant cardiac and cerebrovascular complications. 9 In conclusion, we found that preoperative eGFR predicts perioperative MACCE in a broad spectrum of non-cardiac surgical procedures. The occurrence of MACCE increases with a declining eGFR which is particularly evident for eGFR ,45 ml min 21 1.73 m 22 . We recommend that anaesthesiologists use eGFR in place of creatinine in preoperative cardiovascular evaluation for non-cardiac surgery.
